Authors:
Flechon, A
Lombard-Bohas, C
Boulez, J
Blay, JY
Scoazec, JY
Citation: A. Flechon et al., Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patientwith peritoneal carcinomatosis by liposomal daunorubicin treatment, ANN ONCOL, 12(2), 2001, pp. 275-276
Authors:
Fizazi, K
Tjulandin, S
Salvioni, R
Germa-Lluch, JR
Bouzy, J
Ragan, D
Bokemeyer, C
Gerl, A
Flechon, A
de Bono, JS
Stenning, S
Horwich, A
Pont, J
Albers, P
De Giorgi, U
Bower, M
Bulanov, A
Pizzocaro, G
Aparicio, J
Nichols, CR
Theodore, C
Hartmann, JT
Schmoll, HJ
Kaye, SB
Culine, S
Droz, JP
Mahe, C
Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657
Citation: A. Flechon et al., Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors, J UROL, 165(6), 2001, pp. 1920-1926
Citation: A. Flechon et Jp. Droz, Is there still indication of high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?, B CANCER, 88(9), 2001, pp. 852-857
Citation: A. Flechon et al., High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience, INT J CANC, 83(6), 1999, pp. 844-847
Authors:
Ferbus, D
Flechon, A
Muleris, M
Li, Y
Hanash, S
Terris, B
Hammel, P
Pibouin, L
Dutrillaux, B
Goubin, G
Citation: D. Ferbus et al., Amplification and over-expression of OZF, a gene encoding a zinc finger protein, in human pancreatic carcinomas, INT J CANC, 80(3), 1999, pp. 369-372
Authors:
Flechon, A
Biron, P
Philip, I
Blay, JY
Droz, JP
Citation: A. Flechon et al., High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Leon-Berard between 1982 and 1996, B CANCER, 86(4), 1999, pp. 391-399